Large amino acid transporter 1 mediated glutamate modified mesoporous silica nanoparticles for chemophotothermal therapy

2019 ◽  
Vol 52 ◽  
pp. 784-793 ◽  
Author(s):  
Da Wang ◽  
Qinfu Zhao ◽  
Tongying Jiang ◽  
Luping Sha ◽  
Siling Wang ◽  
...  
2019 ◽  
Vol 282 ◽  
pp. 243-251 ◽  
Author(s):  
Waranya Ratirotjanakul ◽  
Teeraporn Suteewong ◽  
Duangporn Polpanich ◽  
Pramuan Tangboriboonrat

2001 ◽  
Vol 120 (5) ◽  
pp. A153-A153
Author(s):  
S MIYAMOTO ◽  
K KATO ◽  
Y ISHII ◽  
S ASAI ◽  
T NAGAISHI ◽  
...  

2020 ◽  
Vol 20 (11) ◽  
pp. 1001-1016
Author(s):  
Sandra Ramírez-Rave ◽  
María Josefa Bernad-Bernad ◽  
Jesús Gracia-Mora ◽  
Anatoly K. Yatsimirsky

Hybrid materials based on Mesoporous Silica Nanoparticles (MSN) have attracted plentiful attention due to the versatility of their chemistry, and the field of Drug Delivery Systems (DDS) is not an exception. MSN present desirable biocompatibility, high surface area values, and a well-studied surface reactivity for tailoring a vast diversity of chemical moieties. Particularly important for DDS applications is the use of external stimuli for drug release. In this context, light is an exceptional alternative due to its high degree of spatiotemporal precision and non-invasive character, and a large number of promising DDS based on photoswitchable properties of azobenzenes have been recently reported. This review covers the recent advances in design of DDS using light as an external stimulus mostly based on literature published within last years with an emphasis on usually overlooked underlying chemistry, photophysical properties, and supramolecular complexation of azobenzenes.


Sign in / Sign up

Export Citation Format

Share Document